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 
Abstract—Early and accurate identification of parkinsonian 
syndromes (PS) involving presynaptic degeneration from non-
degenerative variants such as Scans Without Evidence of 
Dopaminergic Deficit (SWEDD) and tremor disorders, is 
important for effective patient management as the course, 
therapy and prognosis differ substantially between the two 
groups. In this study, we use Single Photon Emission Computed 
Tomography (SPECT) images from healthy normal, early PD 
and SWEDD subjects, as obtained from the Parkinson's 
Progression Markers Initiative (PPMI) database, and process 
them to compute shape- and surface fitting-based features for the 
three groups. We use these features to develop and compare 
various classification models that can discriminate between scans 
showing dopaminergic deficit, as in PD, from scans without the 
deficit, as in healthy normal or SWEDD. Along with it, we also 
compare these features with Striatal Binding Ratio (SBR)-based 
features, which are well-established and clinically used, by 
computing a feature importance score using Random forests 
technique. We observe that the Support Vector Machine (SVM) 
classifier gave the best performance with an accuracy of 97.29%. 
These features also showed higher importance than the SBR-
based features. We infer from the study that shape analysis and 
surface fitting are useful and promising methods for extracting 
discriminatory features that can be used to develop diagnostic 
models that might have the potential to help clinicians in the 
diagnostic process. 
 
Index Terms—Computer-aided early detection, Parkinson's 
Disease (PD), Scans Without Evidence of Dopaminergic Deficit 
(SWEDD), Pattern classification, Quantification and estimation, 
Shape analysis, Surface fitting 
I. INTRODUCTION 
ARKINSONIAN SYNDROMES (PS) is a group of movement 
disorders that is clinically characterized by symptoms of 
resting tremor, rigidity and bradykinesia [1]. The clinical 
diagnosis of PD based on clinical signs and a good response to 
levodopa, can be straightforward. However, in the early stages 
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of the disease, when the symptoms are mild, atypical or 
ambiguous with unconvincing responses to levodopa, the 
diagnosis can be difficult and inconclusive [1, 2]. The 
Parkinson's Progression Markers Initiative (PPMI) [3] which 
is a landmark large-scale study to identify PD progression 
biomarkers points out that early diagnosis of de novo PD 
subjects, like those being recruited for the study, is difficult 
because the characteristic signs and symptoms of the disease 
have not yet fully emerged (Study Protocol of the PPMI; 
http://www.ppmi-info.org/study-design/research-documents-
and-sops/). Few tremor disorders, such as Essential Tremor 
(ET) that do not depict any dopaminergic deficit, but share 
several clinical features as in PS, can also lead to difficulties 
in the diagnostic process [4]. 
Early and accurate diagnosis of PS involving presynaptic 
degeneration is of prime importance for effective disease 
management and for allowing neuroprotective strategies to be 
administered earlier when they become available [2]. Accurate 
identification is crucial for effective patient management 
because the disease course, prognosis and therapy differ 
substantially from the non-degenerative variants or other 
tremor disorders [4]. 
SPECT imaging using 
123
I-Ioflupane (DaTSCAN or 
[123I]FP-CIT) is presently among the most sensitive imaging 
techniques, even in the early stages of the disease [1, 2, 5]. 
Dopaminergic imaging discriminates patients with 
neurodegenerative PS from healthy normal, non-degenerative 
PS and tremor disorders such as ET by identifying presynaptic 
dopaminergic deficits in the caudate and putamen with high 
sensitivity and specificity [2]. Based on the pattern of uptake 
of the radiotracer, SPECT images can be normal (that shows 
no dopaminergic deficit) or abnormal. Normal scans are 
characterized by intense and symmetric DAT binding in the 
caudate nucleus and putamen on both hemispheres that appear 
as two 'comma' shaped regions (Figs. 2(a) and 2(e)). Any 
asymmetry or distortion of this shape implies an abnormal 
finding (Fig. 2(i)) [1, 4]. A number of studies on early PD 
have observed that about 10–15% of subjects recruited in their 
studies by movement disorder experts with the diagnosis of 
PD, showed Scans Without Evidence of Dopaminergic Deficit 
or normal dopaminergic activity, which led to the coining of 
the term SWEDD [6-8]. Subsequent follow-up showed that 
they neither deteriorate nor respond to levodopa, and that their 
SPECT scans remain normal [8, 9]. It was inferred that they 
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were highly unlikely of having PD. The results from these 
studies clearly point out that dopaminergic imaging is highly 
useful and that an abnormal imaging, at least in cases of 
diagnostic uncertainty, is strongly supportive of a diagnosis of 
neurodegenerative PS. 
In clinical practice, SPECT images are usually evaluated 
visually or through region-of-interest (ROI) analysis [10]. 
Researchers have also carried out voxel-based analysis where 
voxel clusters that show significant decrease in the uptake are 
identified [10-14]. Visual analysis, however, relies on the 
judgement of the observer that heavily depends on his 
expertise and knowledge [10]. ROI techniques involve 
outlining or positioning the ROI over the striatum (target 
region) and the occipital cortex (reference region), and a 
quantitative measure termed the background subtracted striatal 
uptake ratio is computed [10]. Despite odds, the quantitative 
method is the most acceptable one, since, according to Phase 
III trial, it provides an excellent intra- and inter-observer 
agreement. Visual assessment may lead to pitfalls. PPMI 
provides quantified striatal values, called the Striatal Binding 
Ratio (SBR) values, via their database and they are computed 
by nuclear medicine experts of the PPMI (SPECT Manual of 
the PPMI; http://www.ppmi-info.org/study-design/research-
documents-and-sops/). These quantitative measures may be 
more helpful in cases when there is ambiguity in visual 
assessment [15]. On the other hand, voxel-based techniques 
are widely used for scientific purposes but are observed to be 
not practical for use in routine clinical practise [16]. 
An alternate approach is to carry out shape and intensity 
distribution (surface profile) analysis, and use pattern 
recognition techniques for differentiation. This method has the 
following advantages: 1) It does not require positioning of 
ROI, 2) It can be automated or semi-automated thus, avoiding 
or reducing inter-operator and intra-operator variability, 3) 
Shape metric is more strongly associated with the visual 
appearance of the striatal uptake than the striatal uptake ratio 
measurement [15]. To the best of our knowledge, there has 
been only one study [15] which carry out shape analysis to 
assess patients with PS. They observed that it is a viable 
alternative to conventional techniques for analysing SPECT 
images. They segmented regions corresponding to higher 
uptake areas of striatum and quantify the shape by fitting an 
ellipse to the region, followed by computing the aspect ratio of 
the fitted ellipse (they called it as north/south, east/west ratio 
or NSEW ratio in the paper). Although the shape could be 
quantified with many different parameters, they had limited to 
using only this one parameter. The other limitation of the 
study is that they had limited sample size of 52 subjects (27 
with neurodegenerative PS, and 25 had normal scans that 
include healthy normal and subjects with non-degenerative PS 
or movement disorders such as ET). 
Surface fitting is a useful approach that is widely used in 
biomedical applications [17-19]. Surface fitting using implicit 
polynomial functions of degree greater than two can 
efficiently represent surfaces that are more complicated than 
those represented by quadric surfaces (e.g., ellipsoid, 
paraboloid, etc.) [20]. As the intensity distribution in the 
uptake regions also vary during diseased condition, this 
approach can be useful in extracting discriminatory features 
from the distribution pattern. 
Realizing the potential of these techniques, we had 
previously carried out shape analysis [21] and surface fitting 
[22] to extract discriminatory features using a small dataset. In 
this work, we combine and extend them by using a larger 
dataset, compute more relevant shape-based features (such as 
features based on asymmetry of uptake), develop classification 
models, and compare these features with SBR-based features 
that are clinically used. Overall, the study can be summarised 
as follows. We use SPECT scan data of early PD, SWEDD 
and healthy normal subjects and process these images to 
segment the regions of high activity. This is followed by two 
kinds of analysis to extract the features 1) Shape analysis of 
these regions by computing various shape-based features 2) 
Fitting of a cubic surface based on the intensities in these 
segmented regions. We use these features to develop 
classification models to classify degenerative PS (early PD 
group in our study) from healthy normal/non-degenerative 
condition (Normal/SWEDD group) using machine learning 
techniques. Along with this, we also compare these features 
with the SBR-based features in a feature importance 
estimation framework using the Random Forests technique. 
II. MATERIALS AND METHODS 
A. Database and cohort details 
Data used in the preparation of this article were obtained 
from the PPMI database (www.ppmi-info.org/data). For up-to-
date information on the study, please visit www.ppmi-
info.org. PPMI is a landmark, large-scale, international and 
multi-centre study to identify PD progression biomarkers [3].  
We use SPECT imaging data corresponding to the subject's 
screening visit, from the database. The images were 
downloaded on 25
th
 June 2014. The numbers of subjects in the 
study are 208 healthy normal, 427 PD and 80 SWEDD. All the 
PD patients are in the early stage (Hoehn and Yahr (HY) stage 
1 or 2 with mean ± SD as 1.50 ± 0.50) and all the SWEDD 
subjects (these are the newly diagnosed PD patients based on 
clinical symptoms, but show normal dopaminergic imaging) 
show early stage (mean ± SD HY stage as 1.46 ± 0.53) PD 
symptoms. 
B. Image analysis and feature extraction 
1) Preprocessing by PPMI 
All SPECT scan data acquired at the PPMI sites undergo a 
pre-processing procedure before they are publically shared via 
the database. This pre-processing ensures that all scans were 
in the same anatomical alignment (spatially normalized). The 
process include reconstruction from raw projection data, 
attenuation correction, followed by applying a standard 
Gaussian 3D 6.0 mm filter, and then normalizing these images 
to standard Montreal Neurologic Institute (MNI) space [23]. 
We use these pre-processed scans for analysis and the analysis 
pipeline is as shown in Fig. 1.  
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Fig. 1. Processing pipeline 
2) Selection of slices for processing 
A SPECT scan consists of 91 transaxial slices (from bottom 
to top of the head). The radioligand [123I]FP-CIT specifically 
binds to the striatal DAT, and with dopaminergic 
neurodegeneration, DAT density decreases and therefore 
striatal [123I]FP-CIT uptake is reduced. Therefore, striatum is 
the region to look for to observe deterioration in DAT 
imaging. We observe that the slice with the highest striatal 
uptake is near to the 42
nd
 slice. We selected the slices around 
it, from 35
th
 to 48
th
, for each scan for further processing as 
they depict the dopaminergic activity of the subject. A further 
discussion on the basis of slice selection in given in Sec. III.D. 
3) Intensity normalization and Segmentation 
Each slice is normalized to the range [0, 1], and then a mean 
image is generated for a subject. This image is again 
normalized to [0, 1].  
In the next step, image segmentation is carried out to extract 
the high uptake regions, which correspond to the 
dopaminergic activity. This is done by converting it to a 
binary image based on a threshold. The threshold was 
carefully chosen for each image based on empirical 
experiments (by observing closely at the accurateness of the 
segmented regions) (Fig. 2). A further discussion on the 
threshold selection is given in Sec. III.D. Following this, we 
perform two kinds of analysis which are 1) Quantification of 
these regions through shape analysis, and 2) Surface fitting. 
They are described as below. 
4) Shape analysis using shape-based features 
During the course of most degenerative PS, dopamine 
transporters are first lost in the putamen and then in the 
caudate, giving a deficit that proceeds from the posterior to 
anterior striatum (Fig. 1(i)) [15]. Visually, it can be observed 
that the shape of the high activity region changes from 
'comma' to 'dot' shaped. Asymmetry of the uptake regions in 
the two hemispheres is also a usual observation [1].  
In this paper, we segment these uptake regions and quantify 
them using various shape-based features. They are area, major 
axis length, minor axis length, aspect ratio, eccentricity, 
equivalent diameter, orientation, roundness, area asymmetry 
index (AI), major axis length AI, minor axis length AI, aspect 
ratio AI, eccentricity AI, equivalent diameter AI, orientation 
AI, roundness AI. A description of these features is given in 
supplementary document (Table S.I). To compute these 
features, the left side region is kept as reference and the right 
side region is flipped from right to left.  
5) Surface fitting based on intensity distribution  
A polynomial surface is fit based on the intensity 
distribution in the segmented region. We choose polynomial 
model of order 3 (cubic model) for surface fitting as higher 
orders can lead to over-fitting. The cubic model is given by  
𝑓 𝑥, 𝑦 = 𝑝00 + 𝑝10𝑥 + 𝑝01𝑦 + 𝑝20𝑥
2 + 𝑝11𝑥𝑦 + 𝑝02𝑦
2
+ 𝑝30𝑥
3 + 𝑝12𝑥𝑦
2 + 𝑝21𝑥
2𝑦 + 𝑝03𝑦
3      (1) 
where 𝑝𝑖𝑗 ; 𝑖, 𝑗 ∈ {0,1,2,3} are the model coefficients which are 
estimated using linear least-squares method where it 
minimizes the summed square of residuals (or errors). Prior to 
the fitting process, the coordinates { 𝑥𝑖 , 𝑦𝑖 ; 𝑖 = 1,2, … , 𝑛} of 
the pixels in the segmented region is normalized by centering 
them to zero mean and scaling to unit standard deviation. This 
transformation won't change the fit theoretically, but it will 
make the results better conditioned on a computer with finite 
precision. This removes any scaling problems that may arise. 
The pixel size is approximately 2 x 2 mm. 
The goodness-of- fit of the final model is evaluated using 
Sum of squares due to Error (SE), 𝑅2, Adjusted R2 (𝑅2𝑎𝑑𝑗 ) 
and Root Mean Squared Error (RMSE) measures. 
6) Feature set 
The 16 features through shape analysis and 14 features (10 
model coefficients and 4 goodness-of-fit evaluation measures) 
via surface fitting form the feature set. Along with these, we 
compute 4 Striatal Binding Ratio (SBR)-based features using 
the SBR values of the four striatal regions (left and right 
caudate, and left and right putamen) which are available from 
the PPMI database. The SBR based features are caudate SBR, 
putamen SBR, caudate SBR asymmetry index (AI), putamen 
AI. We use these SBR-based features for comparison with the 
shape- and surface fitting-based features. More details are 
provided in the supplementary document (Table S.II). 
From our previous studies [21, 22, 24], we observe that 
shape-, surface fitting- and SBR-based features show good 
variations between early PD (who show dopaminergic deficit) 
and healthy normal or SWEDD (who do not show 
dopaminergic deficit). While comparing the healthy normal 
and SWEDD groups, the features do not show substantial 
variation [21, 22]. These observations are consistent with the 
dopaminergic imaging perspective for early PD, healthy 
normal and SWEDD groups [2].  
C. Statistical Analysis of Features 
The features are tested for statistical significance using 
Wilcoxon rank sum test. Statistically significant (p-
value<0.05) features are used for classification modeling to 
distinguish scans with deficit from the scans without deficit. 
Healthy normal and SWEDD groups show similar 
characteristics on dopaminergic imaging (p-value>0.05, Table 
I).We consider them as a single entity as Normal/SWEDD 
group for further analysis. 
D. Classification of degenerative PS (early PD) from non-
degenerative types (Normal/SWEDD) 
We carry out binary classification (early PD vs. 
Normal/SWEDD) using Support Vector Machine (SVM) [25], 
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Boosted Trees [26], Random Forests [27] and Naïve Bayes 
[28] techniques. We used LIBSVM library [29] for 
classification using SVM, statistics toolbox in MATLAB for 
classification using Naïve Bayes, Boosted Trees and Random 
Forests. The classifiers are evaluated based on 10-fold cross 
validation that is repeated 100 times. 
1) Feature importance estimation 
Along with classification, the Random forests [27] 
technique can also carry out feature importance estimation. In 
this technique, while choosing n out of n observations with 
replacement, it omits on average 37% of observations for each 
decision tree. These are 'out-of-bag' observations. Out-of-bag 
estimates of feature importance are computed by randomly 
permuting out-of-bag data across one feature at a time, and 
estimating the increase in the out-of-bag error due to this 
permutation. The larger the increase in error, higher the 
importance of the feature. 
III. RESULTS AND DISCUSSION 
Fig. 2 illustrates average SPECT image generated, image 
segmentation and surface fitting for a healthy normal, 
SWEDD and early PD subject. It is observed that the uptake 
regions in both normal and SWEDD groups are 'comma' 
shaped, whereas in PD (early stage) the region deteriorates to 
become 'circular' or 'dot' shaped. These shapes are consistent 
with the clinical perspective of the respective conditions. 
SWEDD subjects show normal dopaminergic imaging, 
whereas in PD, the change in shape is due to the deterioration 
or loss of striatal DATs.  
The fitted 3D surfaces for both the left and right side 
regions are similar for normal (Figs. 4(c & d)) and SWEDD 
(Figs. 4(g & h)) groups, indicating a symmetric behavior of 
intensity distributions in these regions. On the other hand, the 
surfaces for PD (Figs. 4(k & l)) show variation between the 
left and the right side, indicating an asymmetry in the intensity 
distributions. Another interesting observation is that the cubic 
surfaces for PD show more positive curvature, whereas for 
normal and SWEDD, it shows a saddle-shaped or surface with 
a negative curvature. This is because during the course of PD, 
DATs are first lost in the putamen (lower portion of the 
segmented regions or striatum), then in the caudate (upper 
portion of the segmented regions), or in other words, it 
proceeds from posterior to anterior striatum [15]. This loss of 
DATs in PD in the putamen (or posterior striatum) leads to the 
loss of negative curvature. Table I lists the values of shape-
based (1 to 16), surface fitting-based (17 to 30) and SBR-
based (31 to 34) features used in the study. 
A. Feature values, statistical analysis and justification for 
considering normal and SWEDD as a single group 
Clinically, it is established that SWEDD subjects show 
dopaminergic imaging characteristics similar to that of healthy 
normal. Table I which shows the values along with the results 
of the statistical testing of the features, are consistent with this 
perspective. Box plots of the computed features also indicate 
the same (included in the supplementary file). 
 
TABLE I 
SHAPE-, SURFACE FITTING- AND SBR-BASED FEATURE VALUES (MEAN ± SD), 
AND STATISTICAL TESTING FOR COMPARING HEALTHY NORMAL VS. SWEDD 
AND EARLY PD VS. NORMAL/SWEDD 
SNo. Features Normal  SWEDD Early PD  p1 p2 
1. Area 122.2 ± 18.9 123.9 ± 16.7 71.8 ± 17.6 0.43 ≈ 0 
2. Major Axis 
Length 
16.58 ± 1.47 16.65 ± 1.4 11.06 ± 1.59 0.64 ≈ 0 
3. Minor axis length 9.67 ± 0.78 9.75 ± 0.66 8.25 ± 1.1 0.52 ≈ 0 
4. Aspect Ratio 1.72 ± 0.13 1.71 ± 0.12 1.35 ± 0.15 0.54 ≈ 0 
5. Eccentricity 0.81 ± 0.03 0.81 ± 0.03 0.63 ± 0.1 0.55 ≈ 0 
6. Equivalent 
diameter 
12.43 ± 0.98 12.52 ± 0.86 9.41 ± 1.21 0.45 ≈ 0 
7. Orientation 49.46 ± 7.89 50.75 ± 7 29.66 ± 17.34 0.26 ≈ 0 
8. Roundness 0.88 ± 0.04 0.89 ± 0.04 1.03 ± 0.06 0.8 ≈ 0 
9. Area AI* 0.07 ± 0.06 0.09 ± 0.1 0.43 ± 0.28 0.75 ≈ 0 
10. Major Axis 
Length AI 
0.06 ± 0.05 0.07 ± 0.06 0.25 ± 0.17 0.5 ≈ 0 
11. Minor axis length 
AI 
0.05 ± 0.04 0.06 ± 0.05 0.2 ± 0.15 0.18 ≈ 0 
12. Aspect Ratio AI 0.08 ± 0.06 0.08 ± 0.06 0.13 ± 0.1 0.67 ≈ 0 
13. Eccentricity AI 0.04 ± 0.04 0.04 ± 0.04 0.23 ± 0.27 0.71 ≈ 0 
14. Equivalent 
diameter AI 
0.03 ± 0.03 0.04 ± 0.05 0.22 ± 0.15 0.75 ≈ 0 
15. Orientation AI 0.12 ± 0.12 0.12 ± 0.09 0.01 ± 0.85 0.89 ≈ 0 
16. Roundness AI 0.05 ± 0.04 0.06 ± 0.05 0.09 ± 0.08 0.97 ≈ 0 
17 𝑝00  0.93 ± 0.02 0.93 ± 0.02 0.92 ± 0.03 0.13 0.15 
18 𝑝10 -0.01 ± 0.02 -0.01 ± 0.02 0.01 ± 0.02 0.55 ≈ 0 
19 𝑝01  -0.09 ± 0.02 -0.09 ± 0.02 -0.03 ± 0.02 0.92 ≈ 0 
20 𝑝20  -0.11 ± 0.01 -0.11 ± 0.01 -0.07 ± 0.01 0.48 ≈ 0 
21 𝑝11 -0.11 ± 0.02 -0.11 ± 0.02 -0.03 ± 0.02 0.65 ≈ 0 
22 𝑝02  -0.11 ± 0.01 -0.11 ± 0.01 -0.07 ± 0.02 0.65 ≈ 0 
23 𝑝30  0.01 ± 0.01 0.01 ± 0.01 0 ± 0.01 0.2 ≈ 0 
24 𝑝21  0.03 ± 0.01 0.02 ± 0.01 0.01 ± 0.01 0.49 ≈ 0 
25 𝑝12 0 ± 0.01 0 ± 0.01 -0.01 ± 0.01 0.97 ≈ 0 
26 𝑝03  0.03 ± 0.01 0.03 ± 0.01 0.01 ± 0.01 0.89 ≈ 0 
27 SE 0.05 ± 0.03 0.06 ± 0.04 0.01 ± 0.01 0.19 ≈ 0 
28 𝑅2 0.96 ± 0.02 0.96 ± 0.02 0.98 ± 0.01 0.26 ≈ 0 
29. 𝑅2𝑎𝑑𝑗  0.96 ± 0.02 0.95 ± 0.03 0.98 ± 0.01 0.26 ≈ 0 
30. RMSE 0.02 ± 0.01 0.02 ± 0.01 0.01 ± 0 0.26 ≈ 0 
31. Caudate SBR 2.97 ± 0.62 2.85 ± 0.57 2.02 ± 0.54 0.26 ≈ 0 
32. Putamen SBR 2.13 ± 0.56 2.06 ± 0.48 0.84 ± 0.31 0.55 ≈ 0 
33. Caudate SBR AI 0.08 ± 0.06 0.08 ± 0.06 0.18 ± 0.12 0.66 ≈ 0 
34. Putamen SBR AI 0.11 ± 0.09 0.12 ± 0.1 0.37 ± 0.25 0.67 ≈ 0 
p1 and p2 represent the p-values of features for healthy normal vs. SWEDD 
comparison and for early PD vs. (healthy normal/SWEDD) comparison, 
respectively. All the features, except the model coefficient 𝑝00 , are highly 
statistically significant (p-value<0.01) in depicting the changes in PD as 
compared to normal or SWEDD. On the other hand, no feature is significant 
(p-value>0.05) while comparing normal and SWEDD groups. 
We observe the following from the table: 
a) Area, major axis length, minor axis length and equivalent 
diameter decreases in PD as compared to the non-
degenerative groups (healthy normal or SWEDD). This 
indicates that the size of uptake regions reduces in PD. 
b) Aspect ratio and eccentricity decreases in PD, becoming 
close to 1 and 0, respectively. Roundness increases, 
becoming close to 1 in PD. This indicates that the uptake 
region becomes more 'circular' or 'dot' shaped in PD. 
c) Orientation decreases in degenerative PS. Its value of 
49.46 ± 7.89 degrees for healthy normal or 50.75 ± 7 
degrees for SWEDD indicate normal uptake in both 
posterior and anterior striatum. However, during PD, its 
value decreases to 29.66 ± 17.34 degrees due to the loss of 
activity that proceeds from posterior to anterior striatum. 
This is consistent with the clinical perspective of PD.  
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Scans Without Evidence of Dopaminegic Deficit (SWEDD) 
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Early PD 
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Fig.2. Slice averaging, image segmentation and surface fitting for healthy normal (a, b, c, d), SWEDD (e, f, g, h), and early PD (i, j, k, l). The shape of the uptake 
region undergoes a change from a 'comma' shaped to more 'circular' or 'dot' shaped during PD as compared to normal or SWEDD. The fitted surfaces also show 
variation during PD as compared to the other groups. No substantial difference is observed between normal and SWEDD groups visually. The figures 2(c, d, g, h, 
k, l) show the fitted surfaces with positive (peaks) and negative (valleys) curvatures based on the intensity values. It is a 3D representation of the intensity values 
with x and y axis representing the image coordinates. The rectangle (or the cuboid in 3D) represents the bounding box of the segmented region. Cubic surfaces 
are fitted separately for the two segmented regions (left and right striatum). The left side is kept as the reference for the fitting process. Therefore, before carrying 
out the fitting process for the right side, the image is flipped right to left. This is carried out so that the coordinates for the left and right are in same scale. The top 
left corner of the image is (0,0) and the bottom right is (91,109). The pixel size is 2 mm × 2 mm.  
d) Coefficients corresponding to linear terms (𝑝10  and 𝑝01) 
and quadratic terms (𝑝11 ,  𝑝20  and 𝑝02) in the cubic model 
are higher, and coefficients corresponding to cubic terms 
(𝑝30 ,  𝑝21 ,  𝑝12  and 𝑝03 ) are lower in PD as compared to the 
other groups. This indicates that the surface corresponding 
to PD is close to quadratic in nature. The constant term 
(𝑝00 ) showed little or no difference between the three 
groups. This is because 𝑝00  essentially reflects the height 
of the curve from the ground (or base surface), and the 
height which is dependent on the overall intensity 
distribution is similar between the groups as it is 
normalized. 𝑝00  has no effect on the curvature of the 
surfaces. The goodness-of-fit measures showing higher 𝑅2 
or 𝑅2𝑎𝑑𝑗 , and lower 𝑆𝐸 or 𝑅𝑀𝑆𝐸 implies that there is 
higher degree of fitting in early PD as compared to other 
groups.  
Table I also shows the results of statistical testing of these 
features, for healthy normal vs. SWEDD comparison and PD 
vs. Healthy Normal/SWEDD group comparison. None of the 
features showed statistical significance (p-value>0.05) while 
comparing healthy normal with SWEDD.  
The basic aim of the study is in discriminating degenerative 
PS from the non-degenerative scans through shape and surface 
fitting in SPECT imaging. As there is no substantial difference 
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between the healthy normal and SWEDD groups, as observed 
from the box plots and statistical analysis (Table I), we 
consider the two groups to form a single Normal/SWEDD 
group for classification modeling process. While comparing 
the early PD group and this combined Normal/SWEDD group, 
we observed that all features, except the model coefficient 𝑝00 , 
showed high statistical significance (p-value<0.05) indicating 
their usefulness in discriminating degenerative PS. 
B. Classification modeling 
Of all the features, 29 features (all features except the model 
coefficient 𝑝00) that are statistically significant are used for 
subsequent classification modeling. Table II shows the 
performance measures obtained for the various classifiers 
used. It is observed that all classifiers performed with a high 
accuracy. SVM classifier (using Radial Basis Function (RBF) 
kernel) gave the highest accuracy (slightly higher than other 
classifiers) and area under the ROC curve (AUC) of 97.29% 
and 99.26%, respectively. The parameters 𝐶 and 𝛾 for SVM 
were obtained using 10-fold cross validation (CV) as 1 and 
0.0625, respectively. 
In our previous work [24], we had showed that SVM 
classifier using SBR features produced an accuracy of 96.14% 
that was higher than the state-of-the-art studies. In this work, 
we observe that SVM classifier (or any other classifier used in 
the study) using shape- and surface fitting-based features gives 
higher accuracy than our previous work. A more detailed 
comparison is given in Sec III.E. 
In the boosted trees model, the minimum size of parent 
node and leaf node is specified as 10 and 5, respectively. The 
number of trees in the model is chosen as 70 based on the 
observation that at this point the 10-fold CV error was 
smallest and the error was almost same after this point. The 
number of trees in the Random forests model is chosen as 65 
based on lower 10-fold CV and out-of-bag errors. 
TABLE II 
PERFORMANCE MEASURES OBTAINED FOR THE CLASSIFIER USED. 
Performance 
measures 
SVM Boosted 
Trees 
Random 
Forests 
Naïve Bayes 
Accuracy  97.29 ± 0.11 96.76 ± 0.23 96.90 ± 0.17 96.88 ± 0.09 
Sensitivity  97.37 ± 0.10 97.09 ± 0.25 97.18 ± 0.23 96.43 ± 0.14 
Specificity  97.18 ± 0.22 96.29 ± 0.42 96.49 ± 0.32 96.47 ± 0.16 
AUC 99.26 ± 0.06 99.16 ± 0.12 99.08 ± 0.11 98.99 ± 0.07 
C. Estimation of importance of features 
Feature importance is carried out to observe the relative 
importance of the features, and to compare the shape-based 
and surface fitting-based features as computed in our study, 
with the standard SBR-based features (computed from SBR 
values that are calculated by experts at PPMI and obtained 
from the PPMI database). Fig. 3 shows the plot of feature 
importance scores for each feature. 
The number of trees in the Random forest model is chosen 
as 75 based on lower 10-fold CV error and out-of-bag error. 
Major axis length, model coefficient 𝑝11  and mean putamen 
SBR are observed to be features of higher importance. Our 
observation of mean putamen SBR being an important feature 
is consistent with previous studies [30, 31] which show that, 
during PD, greater reduction occurs in the putamen than in the 
caudate. Major axis length, which is a feature that reflects the 
spread of the dopaminergic activity, decreases in PD. This is 
consistent with the observation by Staff et al.[15] that, as the 
deterioration progresses, deficit in activity proceeds from 
posterior to anterior striatum which results in a decrease of the 
region of activity. Model coefficient 𝑝11  reflects the curvature 
of the surfaces. Higher the absolute value of this coefficient, 
more negative the surface curvature. Its value is close to 0 
indicating less negative curvature or more positive curvature 
in PD. The loss of curvature in PD is due to the loss of activity 
in the posterior striatum (or the putamen) which is consistent 
with the Staff et al.[15] study. 
 
Fig. 3. Plot of feature importance scores for all features: shape-based (features 
from 1 to 16), surface fitting-based (features from 17 to 30) and SBR-based 
features (features from 31 to 34). x-axis represents features indicated by their 
corresponding numbers as given in Table I. Major axis length (feature number 
2), model coefficient 𝑝11 (feature number 21) and mean putamen SBR (feature 
number 32) are observed to be the most important features. This observation 
is consistent with the clinical perspective of the deterioration process in 
degenerative PS such as in PD. The bold dashed line in the figure corresponds 
to the score of the mean caudate SBR which has the second highest feature 
importance score among the SBR-based features. 10 shape-based and 10 
surface fitting-based features show higher scores than the mean caudate SBR. 
Random forests, which was used for studying variable importance, also 
computes the predictive power using the out-of-bag observations. They are as 
follows: Accuracy=97.07%, Sensitivity = 97.32% and Specificity = 96.69%. 
Mean caudate SBR (feature 31 in Fig. 3) has the second 
highest score among the SBR-based features. To compare 
shape- and surface fitting-based features with SBR-based 
features, we see the relative importance of both with the mean 
caudate SBR. Nine among the 16 shape-based features and 
nine among the 14 surface fitting-based features have higher 
scores than the mean caudate SBR. It indicates that the shape- 
and surface fitting-based features show higher discriminatory 
power and has the potential in distinguishing scans with deficit 
from scans without deficit. 
Along with estimating the feature importance, Random 
forests technique also provides an average out-of-bag error 
which is an unbiased estimator of the true ensemble error and 
an estimate of the predictive power. We observe that using 
SBR-based features along with shape-based and surface 
fitting-based features did not substantially improve the 
classification performances (Accuracy difference = 0.17%). 
This indicates that the shape- and surface fitting-based 
features contained enough information essential for 
classification, and hence, these features have the potential to 
be useful in a clinical setting for the diagnostics of PD.  
In the limitations, the present approach does not involve 
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another main clinical scenario, the differentiation of other 
neurodegenerative parkinsonisms (differential diagnosis), or 
address issues of vascular change affecting dopamine 
transporters. 
D. Note on slice selection and threshold selection 
Our slice selection is based on the Society of Nuclear 
Medicine (SNM) recommendations which mention that at 
least 3 consecutive slices in the target region are to be used—
those with the highest activity [16], and within the same 
center, the number of slices chosen should be kept consistent. 
For illustration, we computed the uptake areas for slices from 
35 to 48 (rest of the slices did not show significant striatal 
activity) as shown in Fig. 4. For our study, we selected slices 
numbered from 35 to 48 and taken their average for further 
analysis. This number was selected based on careful empirical 
experiments making it very less machine dependent.  
 
Fig. 4. Plot of the areas (in pixels) of the segmented striatal regions from 
slices 33 to 50 (from the total 91 slices).  
Our method is not fully automatic, like the classifiers, with 
regard to the threshold selection. Although a threshold is 
applied to the images for segmentation, it is not totally 
subjective as well. This is due to the normalization process 
that is carried out before segmentation. The segmented regions 
are carefully assessed by expert investigator. The means ±SD 
values of the thresholds used for healthy normal, SWEDD and 
early PD are 0.63±0.04, 0.63±0.03 and 0.69±0.05, 
respectively. The plot of histograms of thresholds used for the 
three groups are shown in Figs. 5 (a, b & c), respectively. It is 
important to note that the variability of the thresholds used for 
each group is very low as observed from the very low standard 
deviations, 0.04 (6.34 %), 0.03 (4.76%) and 0.05 (7.24%) for 
healthy, SWEDD and early PD groups, respectively.  
The thresholds used for the PD case is higher due to the 
following. During PD, dopamine transporters (DATs) are first 
lost in the putamen (lower portion of the segmented regions or 
striatum) which correspond to the lower range of intensities in 
the high activity striatal region, then in the caudate (upper 
portion of the segmented regions or the striatum), or in other 
words, it proceeds from the posterior to anterior striatum. Due 
to this, there is loss of the negative curvature regions which 
correspond to the posterior striatum.  
A similar study by Staff et al.[15], where they carry out 
segmentation of the striatal regions using a threshold and then 
quantify its shape using a shape feature. They analyzed the 
reproducibility in terms of inter- and intra-observer variability, 
and observed a good inter- and intra-observer reproducibility. 
 
 
 
(a) 
 
 
(b) 
 
 
(c) 
Fig. 5. Histogram of the thresholds used for segmenting the striatal region in 
(a) healthy normal, (b) SWEDD and (c) Early PD subjects. The thresholds 
used for healthy normal, SWEDD and early PD were 0.63±0.04, 0.63±0.03 
and 0.69±0.05, respectively. 
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E. Comparison with related works 
We discuss the difference in performance and approaches 
between the method used in this study and related works with 
the help of a table as shown below (Table III). 
TABLE III 
PERFORMANCE COMPARISON WITH RELATED WORKS 
Study Sample 
size 
Method Accuracy/
AUC 
Segovia et 
al. [11] 
95 PS, 
94 N 
Extracted voxels from the striatum and 
performed data decomposition using partial 
least squares, followed by classification 
using SVM. 
94.7% 
Illan et al. 
[12] 
100 PS, 
108 N 
Used voxels of the complete brain as 
features and then performed classification 
using a SVM with linear kernel. 
96.81% 
Rojas et al. 
[13] 
41 PS, 
39 N 
Obtained best performance with the 
Principal Component Analysis derived 
features from the high intensity voxels of 
the striatum and classification using SVM 
95% 
Towey et 
al. [14] 
79  PS, 
37 
control 
Used Singular Value Decomposition (SVD) 
to extract significant voxels, followed by 
classification using Naïve Bayes  
94.8% 
Prashanth 
et al. [24] 
369 PD, 
179 N 
Used striatal binding ratio values as 
features, followed by classification using 
SVM  
96.14% 
Staff et al. 
[15] 
27 PS, 
25 
control 
Segmented high uptake areas of striatum, 
and quantified its shape via the aspect ratio 
of the ellipse that was fitted to the region 
94% 
Oliveira et 
al. [32] 
445 PD, 
209 N 
Used voxels from the striatum as features 
and then performed classification using a 
SVM classifier  
97.86% 
Martinez-
Murcia et 
al. [33]* 
158 PD, 
111 N 
Computed Haralick texture features via a 
gray level co-occurrence matrix from the 
brain voxels and used SVM classifier with 
linear kernel. 
97.4% 
* study used three different databases and obtained different accuracies. The 
table shows the highest accuracy. 
Our results are highly competitive when compared to 
related works. It is to be noted that different databases have 
been used in different studies which may bias the comparison. 
The main take away from the present study is that the analysis 
gave high performance using a large database, the PPMI, 
which is one of the large-scale and standard databases publicly 
available for early PD. It is encouraging to observe high 
performance from other studies as well which implies the 
potential of quantification followed by machine learning in 
SPECT imaging for the diagnosis of PD. However, we would 
like to point out that the related works used leave-one-out 
cross validation (LOOCV), which is well known to suffer 
from high variances, for estimating the performance of the 
classifiers. In LOOCV where one sample is used for testing 
and the rest for training, tends to select models with higher 
variances, which may lead to overfitting. In our approach, we 
carry out repeated 10-fold cross validation, as recommended 
by [34], which has lower variance, and therefore tend to give 
more stable models. Also, most of the related works had a 
limitation of smaller database in their study. 
F. Future of DaTSCAN on SWEDD 
 Distinguishing SWEDD from PD is important as most of 
the SWEDD subjects receive unnecessary and inappropriate 
treatment, with huge side-effects, for many years. DaTSCAN 
has shown huge potential in detecting SWEDD. In a number 
of clinical trial studies in early PD, using SPECT imaging as 
the secondary outcome measure, has observed that about 10-
15% of subjects with the clinical diagnosis of PD had 
dopaminergic scans without evidence of dopaminergic deficit 
[2, 8, 35]. Substantial evidence in terms of long-term follow-
up of these subjects indicated poor response to levodopa and 
lack of progression on sequential dopaminergic imaging [6, 9]. 
These suggest that most of these patients do not have 
involvement in the nigrostriatal pathway and do not have PD, 
indicating that this is an issue of misdiagnosis rather than 
inadequate sensitivity of the scan.  
A study done by Schwingenschuh et al. [7] observed that 
adult-onset dystonia is a possible underlying diagnosis for 
SWEDD, rather than PD. Catafau et al. [4] performed a study 
to investigate the clinical impact of 
123
I-Ioflupane SPECT in 
patients with clinically uncertain PS. And they observed that 
after imaging, diagnosis was changed in 52% (61 out of a total 
118) of patients. All patients with a final diagnosis of 
presynaptic PS had an abnormal image, whereas 94% of 
patients with nonpresynaptic PS had a normal scan. Imaging 
increased confidence in diagnosis, leading to changes in 
clinical management in 72% of patients. They also examined 
the relationship between final diagnosis and imaging result, 
123
I-Ioflupane SPECT imaging had an important impact on the 
final diagnosis, by the finding that 100% of patients with a 
final diagnosis of presynaptic PS had an abnormal image 
result, whereas 94% of patients with a final diagnosis of 
nonpresynaptic PS had a normal image result. 
123
I-Ioflupane 
SPECT is therefore a recommended adjunct to the diagnosis of 
patients with uncertain parkinsonism (where there is 
diagnostic uncertainty), especially SWEDD. 
IV. CONCLUSION 
Accurate differential diagnosis of PD from the non-
degenerative PS, tremor disorders or SWEDD cases in their 
early stages is a challenging and important problem. As these 
conditions share many common symptoms, it is a source for 
misdiagnosis. Accurate identification of degenerative PS from 
other non-degenerative variants is crucial for effective patient 
management. In our work, we process SPECT images of 
healthy normal, early PD and SWEDD, and carry out shape 
analysis and surface fitting to compute discriminatory 
features. We observe that the computed shape-based and 
surface fitting-based features show significant variation 
between scans showing dopaminergic deficit from scans 
which did not. The classification models developed using 
these features performed with a high accuracy, sensitivity and 
specificity. It is inferred from the study that shape analysis and 
surface fitting are useful approaches to develop classification 
models that can aid a clinician in quantitatively observing the 
deterioration and thereby, aiding in the diagnostic process. 
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